Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,924 | -36,478 | -22,930 | -44,137 | -27,082 |
| Depreciation Amortization | 8,664 | 5,777 | 2,889 | 11,432 | 8,586 |
| Accounts receivable | -4,413 | -4,476 | -3,129 | 1,094 | -1,228 |
| Other Working Capital | -6,951 | -4,073 | -4,992 | -9,957 | -15,241 |
| Other Operating Activity | 10,661 | 7,936 | 4,762 | 5,809 | 5,695 |
| Operating Cash Flow | $-43,963 | $-31,314 | $-23,400 | $-35,759 | $-29,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -477 | -242 | -135 | -159 | -144 |
| Investing Cash Flow | $-477 | $-242 | $-135 | $-159 | $-144 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -21 | -14 | -6 | -23 | -18 |
| Common Stock Issued | 102,781 | 21,293 | 21,360 | 84,721 | 84,553 |
| Other Financing Activity | -803 | -733 | -708 | -1,106 | -1,100 |
| Financing Cash Flow | $101,957 | $20,546 | $20,646 | $83,592 | $83,435 |
| Beginning Cash Position | 71,546 | 71,546 | 71,546 | 23,872 | 23,872 |
| End Cash Position | 129,063 | 60,536 | 68,657 | 71,546 | 77,893 |
| Net Cash Flow | $57,517 | $-11,010 | $-2,889 | $47,674 | $54,021 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,963 | -31,314 | -23,400 | -35,759 | -29,270 |
| Capital Expenditure | -477 | -242 | -135 | -159 | -144 |
| Free Cash Flow | -44,440 | -31,556 | -23,535 | -35,918 | -29,414 |